2012 Deep Research Report on China Influenza Vaccine Industry

May 9, 2012 - PRLog -- 2012 Deep Research Report on China Influenza Vaccine Industry

Hard copy: 2200 USD
Electronic copy (PDF):2200USD
Global License: 4000USD
Pages: 144
Tables and Figures: 155
Published Date: May 9 2012
Publisher: QY Research Group
Contact: Mr. Zhang Dong 86-10-82945717 86-13811796901 sales@qyresearch.com

Summary

was a professional and depth research report on China Influenza Vaccine Industry. Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and equipments List etc; then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2016 Capacity production cost price production value profit margins and other relevant data, statistics these enterprises Influenza Vaccine products, Product Specifications, company background information, then summary statistics and analysis the relevant data on these enterprises. The report got Global and China Influenza Vaccine companies production market share, China Influenza Vaccine demand supply and shortage, China Influenza Vaccine 2009-2016 production price cost profit production value profit margins, production market share by different Sources(China Domestic and Imported etc) . At the same time, the report analyzed and discussed supply and demand changes in Influenza Vaccine market and business development strategies, conduct a comprehensive analysis on China Influenza Vaccine industry trends. Finally, the report also introduced 8Million Pieces/year Influenza Vaccine project Feasibility analysis and related research conclusions. In a word, It was a depth research report on China Influenza Vaccine industry. And thanks to the support and assistance from Influenza Vaccine industry chain related experts and enterprises during QYResearch Vaccine Research Team survey and interview.



Table of Contents

Chapter One Influenza Vaccine Industry Overview 1
1.1 Definition 1
1.2 Classification 2
1.2.1 Seasonal Influenza Vaccine 2
1.2.2 Type A H1N1 Influenza Vaccine 4
1.2.3 Two Type Influenza Vaccine Comparison 6
1.3 Vaccine Inoculation 7
1.4 Industry Chain Structure 9
1.5Influenza Vaccine Development Prospect 15
1.5.1 United States Overplus 15
1.5.2 Seek Competitive Differentiation New Technology Prevalence 17
1.5.3 Huge Market Demand in China 18

Chapter Two Influenza Vaccine Manufacturing Technology and Process 19
2.1 Influenza Vaccine Manufacturing Technology Overview 19
2.1.1 Embryo Culture Type A H1N1 Influenza Vaccine Manufacturing Process 20
2.1.2 Vero Cell Culture Inactivated Influenza Vaccine Manufacturing Process 23
2.2 Comparison of Two Procee Method 26
2.2.1 Embryo Culture Inactivated Influenza Vaccine Process Flow 26
2.2.2 Cell Culture Inactivated Influenza Vaccine Process Flow 27
2.2.3 Two Manufacturing Process Comparison 28
2.3 Influenza Vaccine Manufacturing Equipments List 30
2.4 Influenza Vaccine Manufacturing Process Today and Tomorrow 33
2.4.1 Influenza Vaccine Manufacturing Process Status 33
2.4.2 H1N1 Influenza Vaccine Manufacturing Process Problems 33
2.4.3 Influenza Vaccine New Manufacturing Technology 34

Chapter Three Influenza Vaccine Production Supply Sales Demand Market Status and Forecast 38
3.1 Influenza Vaccine Productions Overview 38
3.2 Influenza Vaccine Demand Overview 49
3.4 Influenza Vaccine Cost Price Production Value Gross Margin 53

Chapter Four Influenza Vaccine Key Manufacturers 57
4.1 Hualan Bio (Henan) 57
4.2 Sinovac (Beijing) 65
4.3 Tianyuan Bio-pharma (Zhejiang) 73
4.4 Changsheng (Jilin Changchun) 77
4.5 Aleph Biomedical (Liaoning) 81
4.6 SIOBP (Shanghai) 87
4.7 CCBIO (Jilin Changchun) 91
4.8 Lanzhou Institute of Biological Products (Qinghai) 95
4.9 Tiantan Biological (Beijing) 99
4.10 Sanofi-pasteur (France) 105
4.11 GSK (UK) 109
4.12 Novartis (Switzerland) 116
4.13 Abbott (US) 122
4.14 Crucell (Holland) 125
4.15 Tasly&Jenner (Tianjin) 130
4.16 Neptunus Interlong (Shenzhen) 134

Chapter Five China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 139
5.1 China 8Million Pieces/Year Influenza Vaccine Project Opportunities and Risks Analysis 139
5.1.1 Opportunities 139
5.1.2 Risks 140
5.3 China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis 140
5.3.1 Project Overview 141
5.3.2 Capacity 141
5.3.3 Construction Standards 141
5.3.3 Construction Period 141
5.3.4 Project Schedule 141
5.3.5 Investment Feasibility Analysis 142

Chapter Six Influenza Vaccine Industry Research Conclusions 143


Tables and Figures

Table Common Vaccines Classification 2
Table Three Type Influenza Vaccine (Inactivated Whole Virus Vaccine Split Vaccine Subunit Vaccine) Characteristic Comparison 4
Table United States Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 5
Table Europe Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List 6
Figure China First Type Vaccine and Second Type Vaccine Classification and Application 10
Table First Type Vaccine and Second Type Vaccine Detail Market Analysis 10
Table 2009-2010 China First Type Vaccine and Second Type Vaccine Issue Number (10K Pieces) and Market Share 11
Figure 2010 State-owned Private Foreign Enterprise Market Share in First Type Vaccine and Second Type Vaccine 11
Figure Influenza Vaccine Industry Chain Structure 12
Figure Vaccine Cold Chain Circulation System 13

Figure Vaccine Transportation Model 13
Figure First Type Vaccine Transportation Channel 14
Figure Second Type Vaccine Transportation Channel 14
Figure Vaccine Transportation Steps and Process 15
Figure 2009-2019 Global Influenza Vaccine Market Scale(100 Million USD) 16
Figure 2007-2008 United States TOP5 Suppliers Influenza Vaccine Market Share 17
Figure China Influenza Vaccine Inoculation Coverage Rate and Its Gap to International Goal 18
Table Baxter Vero Cell Platform Background Information 23
Figure Embryo Culture Inactivated Vaccine Manufacturing Process Flow 26
Figure Cell Culture Inactivated Influenza Vaccine Manufacturing Process Flow 27
Figure Two Influenza Vaccine Manufacturing Process Comparison 28
Figure Influenza Vaccine Manufacturing Steps 30
Figure Influenza Vaccine Detection Steps 31
Table Influenza Vaccine Manufacturing Equipments List (38 Equipments) 32
Figure Influenza Vaccine Production Periodic Table 33
Figure Influenza Vaccine Production schedules 34
Table Influenza Vaccine Development History 35
Table Existing and R&D Influenza Vaccine Products List 35
Figure Influenza Vaccine New Manufacturing Technology 37
Table China 11 Manufacturers Influenza Vaccine Market Status List 38
Table Selling Influenza Vaccine in China 5 Foreign Suppliers List 39
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Capacity and Total Capacity (10K Pieces) List 40
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Capacity Market Share List 40
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Production and Total Production (10K Pieces) List 41
Table 2009-2016 China 11 Manufacturers Influenza Vaccine Production Market Share List 42
Table 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) and Capacity Utilization Rate 42
Figure 2009-2016 China Influenza Vaccine Capacity Production (10K Pieces) and Growth Rate 43
Figure 2011 China Key Manufacturers Influenza Vaccine Production Market Share (China Government Approcal Data) 43
Table 2009-2016 Global Key Suppliers Influenza Vaccine Capacity and Total Capacity (100 Million Pieces) List 43
Table 2009-2016 Global Key Suppliers Influenza Vaccine Production and Total Production (100 Million Pieces) List 44